Breast Imaging Market Size, Growth, Trends | Report 2023-2032
The global breast imaging systems market was valued at USD 4.74 billion in 2022 and it is predicted to surpass around USD 10.89 billion by 2032 with a CAGR of 8.67% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 4.74 billion |
| Revenue Forecast by 2032 | USD 10.89 billion |
| Growth rate from 2023 to 2032 | CAGR of 8.67% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | GE Healthcare; Hologic, Inc.; Philips Healthcare; Gamma Medica, Inc.; Siemens Healthcare; Fujifilm Holdings Corp., SonoCine, Inc.; Toshiba Corporation; Dilon Technologies, Inc.; Aurora Imaging Technology, Inc. |
Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the market. According to the World Cancer Research Fund (WCRF) by 2030, the number of cases of breast cancer is likely to reach about 2.1 million globally. Also, as per the World Health Organization report on breast cancer released in March 2021, over 2.3 million women globally were diagnosed with the disease in 2020, with approximately 685,000 dying as a result of its severity. Breast imaging is the primary method of diagnosis for a vast majority of breast cancer patients globally. This aspect is expected to contribute to the growth of the market during the forecast period.
In recent years, the rising frequency of breast cancer and its associated mortality at a young age, as well as its delayed presentation, has prompted women to seek medical attention as immediately. Many breast cancer cases in developing countries are discovered at a late stage due to a lack of information about early warning symptoms and screening methods. As a result, numerous organizations all around the world are implementing breast cancer awareness initiatives and campaigns.
These screening programs have been shown to save lives compared to unscreened populations. Thus, rising screening programs and government initiatives are anticipated to upsurge the awareness associated with the diagnosis and treatment of breast cancer and thus might eventually aid the breast imaging market growth. Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and the way it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods like CT scans, MRIs, PET, and others. Furthermore, the quality of breast pictures, patient comfort, and patient dose have all been enhanced by these integrated imaging modalities. Thereby, owing to these advantages, manufacturers across the globe are concentrating more on the introduction of new products to improve the sensitivity and precision of breast cancer diagnostics.
The adoption of highly sophisticated imaging methods and systems for breasts as well as advances in the detection of breast cancer are predicted to accelerate market expansion. Hence owing to the aforementioned factors, the market is anticipated to propel at high growth rates. However, the high cost of imaging systems and the adverse effects of radiation exposure are expected to hinder the growth of the studied market in the forecast period.
Breast Imaging Market Segmentations:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Breast Imaging Market
5.1. COVID-19 Landscape: Breast Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Breast Imaging Market, By Technology
8.1. Breast Imaging Market, by Technology, 2023-2032
8.1.1. Ionizing
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Non Ionizing
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Breast Imaging Market, By End-use
9.1. Breast Imaging Market, by End-use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Breast Care Centers
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Diagnostic Imaging Centers
9.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Breast Imaging Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology (2019-2032)
10.1.2. Market Revenue and Forecast, by End-use (2019-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Technology (2019-2032)
10.1.3.2. Market Revenue and Forecast, by End-use (2019-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Technology (2019-2032)
10.1.4.2. Market Revenue and Forecast, by End-use (2019-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology (2019-2032)
10.2.2. Market Revenue and Forecast, by End-use (2019-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Technology (2019-2032)
10.2.3.2. Market Revenue and Forecast, by End-use (2019-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Technology (2019-2032)
10.2.4.2. Market Revenue and Forecast, by End-use (2019-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Technology (2019-2032)
10.2.5.2. Market Revenue and Forecast, by End-use (2019-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Technology (2019-2032)
10.2.6.2. Market Revenue and Forecast, by End-use (2019-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology (2019-2032)
10.3.2. Market Revenue and Forecast, by End-use (2019-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Technology (2019-2032)
10.3.3.2. Market Revenue and Forecast, by End-use (2019-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Technology (2019-2032)
10.3.4.2. Market Revenue and Forecast, by End-use (2019-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Technology (2019-2032)
10.3.5.2. Market Revenue and Forecast, by End-use (2019-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Technology (2019-2032)
10.3.6.2. Market Revenue and Forecast, by End-use (2019-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology (2019-2032)
10.4.2. Market Revenue and Forecast, by End-use (2019-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Technology (2019-2032)
10.4.3.2. Market Revenue and Forecast, by End-use (2019-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Technology (2019-2032)
10.4.4.2. Market Revenue and Forecast, by End-use (2019-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Technology (2019-2032)
10.4.5.2. Market Revenue and Forecast, by End-use (2019-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Technology (2019-2032)
10.4.6.2. Market Revenue and Forecast, by End-use (2019-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology (2019-2032)
10.5.2. Market Revenue and Forecast, by End-use (2019-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Technology (2019-2032)
10.5.3.2. Market Revenue and Forecast, by End-use (2019-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Technology (2019-2032)
10.5.4.2. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 11. Company Profiles
11.1. GE Healthcare
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Hologic, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Philips Healthcare
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Gamma Medica, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Siemens Healthcare
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Fujifilm Holdings Corp.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. SonoCine, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Toshiba Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Dilon Technologies, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Aurora Imaging Technology, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers